Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

VYGR holding history

Voyager Therapeutics, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VYGR overviewAll 13F holders of VYGRFull Q2 2026 holdings

Shares (Q2 2026)
500
Value
$1.75K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VYGR by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026500$1.75K<0.1%00.0%UnchangedHolders
Q1 2026500$1.93K<0.1%−500−50.0%ReducedHolders
Q4 20251,000$3.93K<0.1%−500−33.3%ReducedHolders
Q3 20251,500$7.00K<0.1%+1,000+200.0%AddedHolders
Q2 2025500$1.55K<0.1%−500−50.0%ReducedHolders
Q1 20251,000$3.38K<0.1%00.0%UnchangedHolders
Q4 20241,000$5.67K<0.1%00.0%UnchangedHolders
Q3 20241,000$5.85K<0.1%00.0%UnchangedHolders
Q2 20241,000$7.91K<0.1%00.0%UnchangedHolders
Q1 20241,000$9.31K<0.1%+500+100.0%AddedHolders
Q4 2023500$4.22K<0.1%00.0%UnchangedHolders
Q3 2023500$3.88K<0.1%00.0%UnchangedHolders
Q2 2023500$5.72K<0.1%00.0%UnchangedHolders
Q1 2023500$3.85K<0.1%00.0%UnchangedHolders
Q4 2022500$3.05K<0.1%00.0%UnchangedHolders
Q3 2022500$3.00K<0.1%00.0%UnchangedHolders
Q2 2022500$3.00K<0.1%00.0%UnchangedHolders
Q1 2022500$4.00K<0.1%00.0%UnchangedHolders
Q4 2021500$1.00K<0.1%−2,000−80.0%ReducedHolders
Q3 20212,500$7.00K<0.1%00.0%UnchangedHolders
Q2 20212,500$10.0K<0.1%00.0%UnchangedHolders
Q1 20212,500$12.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.